Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salvatore Battaglia

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 3, 2010
Wandering coronary stenoses: adrenaline-induced coronary artery spasm in a patient resuscitated from cardiac arrestSalvatore Battaglia, Wail Nammas
Respiratory Research|January 7, 2017
Eligibility of real-life patients with COPD for inclusion in RCTs: a commentarySalvatore Battaglia, Nicola Scichilone
Respiration; International Review of Thoracic Diseases|September 5, 2016
The Importance of Phenotyping BronchiectasisSalvatore Battaglia, Antoni Torres, Eva Polverino
The Journal of Allergy and Clinical Immunology|September 12, 2013
Reply: To PMID 23639306Nicola Scichilone, Salvatore Battaglia, Vincenzo Bellia
Chest|August 10, 2016
Serum Surfactant Protein D as a Marker of Asthma SeverityAlida Benfante, Salvatore Battaglia, Nicola Scichilone
Expert Review of Clinical Immunology|September 12, 2015
Asthma in the older adult: presentation, considerations and clinical managementSalvatore Battaglia, Alida Benfante, Nicola Scichilone
Breathe (Sheffield, England)|April 12, 2016
Asthma in the elderly: a different disease?Salvatore Battaglia, Alida Benfante, Mario Spatafora, et al.
COPD|November 22, 2014
Prevalence of Co-morbidities and Severity of COPDSalvatore Battaglia, Marco Basile, Nicola Scichilone, et al.
Expert Opinion on Drug Safety|April 16, 2019
Are biological drugs effective and safe in older severe asthmatics?Alida Benfante, Stefania Principe, Salvatore Battaglia, et al.
Respiration; International Review of Thoracic Diseases|November 28, 2013
What proportion of chronic obstructive pulmonary disease outpatients is eligible for inclusion in randomized clinical trials?Nicola Scichilone, Marco Basile, Salvatore Battaglia, et al.
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 3, 2010
Wandering coronary stenoses: adrenaline-induced coronary artery spasm in a patient resuscitated from cardiac arrestSalvatore Battaglia, Wail Nammas
Respiratory Research|January 7, 2017
Eligibility of real-life patients with COPD for inclusion in RCTs: a commentarySalvatore Battaglia, Nicola Scichilone
Respiration; International Review of Thoracic Diseases|September 5, 2016
The Importance of Phenotyping BronchiectasisSalvatore Battaglia, Antoni Torres, Eva Polverino
The Journal of Allergy and Clinical Immunology|September 12, 2013
Reply: To PMID 23639306Nicola Scichilone, Salvatore Battaglia, Vincenzo Bellia
Chest|August 10, 2016
Serum Surfactant Protein D as a Marker of Asthma SeverityAlida Benfante, Salvatore Battaglia, Nicola Scichilone
Expert Review of Clinical Immunology|September 12, 2015
Asthma in the older adult: presentation, considerations and clinical managementSalvatore Battaglia, Alida Benfante, Nicola Scichilone
Breathe (Sheffield, England)|April 12, 2016
Asthma in the elderly: a different disease?Salvatore Battaglia, Alida Benfante, Mario Spatafora, et al.
COPD|November 22, 2014
Prevalence of Co-morbidities and Severity of COPDSalvatore Battaglia, Marco Basile, Nicola Scichilone, et al.
Expert Opinion on Drug Safety|April 16, 2019
Are biological drugs effective and safe in older severe asthmatics?Alida Benfante, Stefania Principe, Salvatore Battaglia, et al.
Respiration; International Review of Thoracic Diseases|November 28, 2013
What proportion of chronic obstructive pulmonary disease outpatients is eligible for inclusion in randomized clinical trials?Nicola Scichilone, Marco Basile, Salvatore Battaglia, et al.
Pageof 13